Ambiguous Role of SATB1 Expression in Malignant Tumors
- PMID: 30660670
- DOI: 10.1016/j.jid.2019.01.001
Ambiguous Role of SATB1 Expression in Malignant Tumors
Comment in
-
Response to Gagat et al.J Invest Dermatol. 2019 Jul;139(7):1611-1612. doi: 10.1016/j.jid.2019.01.032. Epub 2019 Mar 12. J Invest Dermatol. 2019. PMID: 30876801 No abstract available.
-
Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary Syndrome.J Invest Dermatol. 2020 Mar;140(3):713-716. doi: 10.1016/j.jid.2019.07.714. Epub 2019 Aug 26. J Invest Dermatol. 2020. PMID: 31465740 Free PMC article. No abstract available.
Comment on
-
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile.J Invest Dermatol. 2018 Aug;138(8):1795-1804. doi: 10.1016/j.jid.2018.02.028. Epub 2018 Mar 3. J Invest Dermatol. 2018. PMID: 29510190
-
SATB1 in Malignant T Cells.J Invest Dermatol. 2018 Aug;138(8):1805-1815. doi: 10.1016/j.jid.2018.03.1526. Epub 2018 May 8. J Invest Dermatol. 2018. PMID: 29751003
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
